13F HOLDINGS REPORT
HealthCor Management, L.P.
Quarter ended Q1 2023 · Filed February 15, 2023 · Accession 0001343781-23-000001
Total Value
$109.1M
Positions
22
Other Managers
0
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BIOMARIN PHARMACEUTICAL INC | BMRN | 367,765 | $38.1M | 34.88% |
| 2 | DEXCOM INC | DXCM | 321,380 | $36.4M | 33.35% |
| 3 | CYTOKINETICS INC | CYTK | 164,440 | $7.5M | 6.91% |
| 4 | ACRIVON THERAPEUTICS INC | ACRV | 284,201 | $3.3M | 3.00% |
| 5 | HYPERFINE INC | HYPR | 3,880,900 | $3.3M | 2.99% |
| 6 | ALKERMES PLC | ALKS | 110,000 | $2.9M | 2.63% |
| 7 | CONMED CORP | CNMD | 27,500 | $2.4M | 2.23% |
| 8 | NEUROCRINE BIOSCIENCES INC | NBIX | 20,000 | $2.4M | 2.19% |
| 9 | SYNDAX PHARMACEUTICALS INC | SNDX | 70,000 | $1.8M | 1.63% |
| 10 | CHINOOK THERAPEUTICS INC | 16961L106 | 60,000 | $1.6M | 1.44% |
| 11 | INTUITIVE SURGICAL INC | ISRG | 5,750 | $1.5M | 1.40% |
| 12 | BLUEPRINT MEDICINES CORP | 09627Y109 | 30,000 | $1.3M | 1.20% |
| 13 | GERON CORP | GERN | 500,000 | $1.2M | 1.11% |
| 14 | PENUMBRA INC | PEN | 5,000 | $1.1M | 1.02% |
| 15 | ROCKET PHARMACEUTICALS INC | RCKTW | 50,000 | $978,500 | 0.90% |
| 16 | RAIN ONCOLOGY INC | 75082Q105 | 120,000 | $960,000 | 0.88% |
| 17 | INSPIRE MED SYS INC | 457730109 | 3,500 | $881,580 | 0.81% |
| 18 | SILK RD MED INC | 82710M100 | 15,000 | $792,750 | 0.73% |
| 19 | IMMUNOGEN INC | 45253H101 | 150,000 | $744,000 | 0.68% |
| 20 | EQRX INC | 26886C115 | 35,239 | $9,451 | 0.01% |
| 21 | EUCRATES BIOMEDICAL ACQU COR | G3141W122 | 78,059 | $4,340 | 0.00% |
| 22 | MEDICUS SCIENCES ACQUISITION | G5960S124 | 29,776 | $2,679 | 0.00% |